发明名称 |
ORF2 PROTEIN OF PCV2 SUBTYPE A (PCV2A) FOR USE IN CROSS-PROTECTION |
摘要 |
Vaccination methods to control PCV2 infection with different PCV2 subtypes are disclosed. Specifically, a PCV2 subtype a (PCV2a) ORF2 proteins or immunogenic compositions comprising a PCV2a ORF2 protein are used in a method for the treatment or prevention of an infection with PCV2 of a different subtype, the reduction, prevention or treatment of clinical signs caused by an infection with PCV2 of a different subtype, or the prevention or treatment of a disease caused by an infection with PCV2 of a different subtype. |
申请公布号 |
US2014322267(A1) |
申请公布日期 |
2014.10.30 |
申请号 |
US201414263193 |
申请日期 |
2014.04.28 |
申请人 |
HAIWICK Gregory;HERNANDEZ Luis;JOHNSON Wesley Scott;MUEHLENTHALER Christine Margaret;VAUGHN Eric Martin |
发明人 |
HAIWICK Gregory;HERNANDEZ Luis;JOHNSON Wesley Scott;MUEHLENTHALER Christine Margaret;VAUGHN Eric Martin |
分类号 |
A61K39/12;A61K39/108;A61K39/08;A61K39/02;A61K39/215;A61K39/145;A61K39/04;A61K39/085;A61K39/09;A61K39/23;A61K39/245;A61K39/05;A61K39/235 |
主分类号 |
A61K39/12 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for the treatment or prevention of an infection with PCV2 of a subtype other than subtype a, the reduction, prevention or treatment of clinical signs caused by an infection with PCV2 of a subtype other than subtype a, or the prevention or treatment of a disease caused by an infection with PCV2 of a subtype other than subtype a comprising the use of a PCV2 subtype a (PCV2a) ORF2 protein or immunogenic composition comprising PCV2a ORF2 protein. |
地址 |
Ankeny IA US |